| 000 | 01172 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513070622.0 | ||
| 264 | 0 | _c19940126 | |
| 008 | 199401s 0 0 eng d | ||
| 022 | _a0026-895X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMichel, M C | |
| 245 | 0 | 0 |
_aSelective irreversible binding of chloroethylclonidine at alpha 1- and alpha 2-adrenoceptor subtypes. _h[electronic resource] |
| 260 |
_bMolecular pharmacology _cDec 1993 |
||
| 300 |
_a1165-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3T3 Cells |
| 650 | 0 | 4 | _aAdrenergic alpha-1 Receptor Antagonists |
| 650 | 0 | 4 | _aAdrenergic alpha-2 Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aClonidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xmetabolism |
| 700 | 1 | _aKerker, J | |
| 700 | 1 | _aBranchek, T A | |
| 700 | 1 | _aForray, C | |
| 773 | 0 |
_tMolecular pharmacology _gvol. 44 _gno. 6 _gp. 1165-70 |
|
| 999 |
_c8263835 _d8263835 |
||